MAPT and Alzheimer disease: Researchers have developed several valuable algorithms that may be used with a wide variety of data sources to diagnose AD based on medical imaging [8]. Biomarkers tau and amyloid beta (Aβ) are measured via PET and lumbar puncture (LP) to acquire cerebrospinal fluid (CSF) [9].